Get started
Author

Aeesha Ranavaya

ORCID: 0000-0001-7806-2234
Observed ORCID: 0000-0001-7806-2234
OpenAlex ID: A5019748093
Progression-Free Survival and Patterns of Response in Patients With Relapsed High-Risk Neuroblastoma Treated With Irinotecan/Temozolomide/Dinutuximab/Granulocyte-Macrophage Colony-Stimulating Factor
2022 · Benjamin J. Lerman, Yimei Li, et al. · Journal of Clinical Oncology · 46
Measles Oncolytic Virus as an Immunotherapy for Recurrent/Refractory Pediatric Medulloblastoma and Atypical Teratoid/Rhabdoid Tumor: Results from PNOC005
2025 · Bohyeon Yu, Cassie Kline, et al. · Clinical Cancer Research · 12
MPL Y252H and MPL F126fs Mutations in Essential Thrombocythemia: Case Series and Review of Literature
2019 · Ahmed G. Elsayed, Aeesha Ranavaya, et al. · Hematology Reports · 7
PDF
Trls-11. Pnoc005: Oncolytic Measles Virus for the Treatment of Children and Young Adults With Recurrent Medulloblastoma or Atypical Teratoid Rhabdoid Tumor
2024 · Cassie Kline, Bohyeon Yu, et al. · Neuro-Oncology · 3
PDF
Progression-free survival and patterns of response in patients with high-risk neuroblastoma (HR-NB) treated with irinotecan/temozolomide/dinutuximab/granulocyte-macrophage colony-stimulating factor (I/T/DIN/GM-CSFS) chemoimmunotherapy.
2022 · Benjamin Lerman, Yimei Li, et al. · Journal of Clinical Oncology · 2
Data from Measles Oncolytic Virus as an Immunotherapy for Recurrent/Refractory Pediatric Medulloblastoma and Atypical Teratoid/Rhabdoid Tumor: Results from PNOC005
2025 · Bohyeon Yu, Cassie Kline, et al. · 1
Clearing the Air: The Importance of Adolescent History Taking in a Modern Medical Age
2020 · Aeesha Ranavaya, Paul Warren, et al. · Clinical Pediatrics
Works count: 7
Citation count: 71
H-index: 3
I10-index: 2
Year
Topic
Type